Cantel Medical Corp. Cl B | Income Statement
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
425,026.00
488,749.00
565,004.00
664,755.00
770,157.00
871,922
Cost of Goods Sold (COGS) incl. D&A
241,550.00
286,091.00
322,821.00
364,110.00
416,524.00
475,308
Gross Income
183,476.00
202,658.00
242,183.00
300,645.00
353,633.00
396,614
SG&A Expense
119,769.00
130,808.00
159,431.00
199,527.00
238,608.00
274,944
EBIT
63,707.00
71,850.00
82,752.00
96,564.00
110,145.00
121,670
Unusual Expense
519.00
922.00
1,991.00
687.00
265.00
6
Non Operating Income/Expense
222.00
209.00
2,206.00
-
126.00
1,138
Interest Expense
2,673.00
2,171.00
2,432.00
3,408.00
4,303.00
5,289
Pretax Income
60,354.00
68,611.00
76,191.00
93,931.00
106,233.00
117,513
Income Tax
21,115.00
25,346.00
28,238.00
33,978.00
34,855.00
26,472
Consolidated Net Income
38,631.00
42,684.00
47,520.00
59,465.00
70,947.00
90,721
Net Income
38,631.00
42,684.00
47,520.00
59,465.00
70,947.00
90,721
Net Income After Extraordinaries
38,631.00
42,684.00
47,520.00
59,465.00
70,947.00
90,721
Net Income Available to Common
38,631.00
42,684.00
47,520.00
59,465.00
70,947.00
90,721
EPS (Basic)
0.95
1.04
1.15
1.44
1.71
2.18
Basic Shares Outstanding
40,267.90
40,751.60
41,139.50
41,344.00
41,468.50
41,567.70
EPS (Diluted)
0.95
1.04
1.15
1.44
1.71
2.18
Diluted Shares Outstanding
40,556.90
40,911.30
41,202.60
41,390.20
41,542.80
41,635.10
EBITDA
80,970.00
90,736.00
106,709.00
121,648.00
143,597.00
156,500
Other Operating Expense
-
-
-
4,554.00
4,880.00
-
Non-Operating Interest Income
61.00
63.00
68.00
88.00
-
-
Other After Tax Income (Expense)
608.00
581.00
433.00
488.00
431.00
320
About Cantel Medical
View Profile
